Cargando…
Chemoprevention of prostate cancer: Natural compounds, antiandrogens, and antioxidants – In vivo evidence
Prostate cancer is the leading non-skin malignancy detected in US males and the second cause of death due to male cancer, in the US. Interventions with drugs or diet supplements that slow down the growth and progression of prostate cancer are potentially very effective in reducing the burden of pros...
Autores principales: | Özten-Kandaş, Nur, Bosland, Maarten C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3243088/ https://www.ncbi.nlm.nih.gov/pubmed/22190869 http://dx.doi.org/10.4103/1477-3163.90438 |
Ejemplares similares
-
Sulforaphane, a Chemopreventive Compound Induces Necrotic Behavior and Inhibits S-phase of Cell Cycle in Human Kidney Cells in Vitro
por: Gokay, Guzin, et al.
Publicado: (2022) -
Resistance to Antiandrogens in Prostate Cancer: Is It Inevitable, Intrinsic or Induced?
por: Maitland, Norman J.
Publicado: (2021) -
Investigating differential miRNA expression profiling using serum and urine specimens for detecting potential biomarkers for early prostate cancer diagnosis
por: HASANOĞLU, Sevde, et al.
Publicado: (2021) -
Resistance to second generation antiandrogens in prostate cancer: pathways and mechanisms
por: Verma, Shiv, et al.
Publicado: (2020) -
Enzalutamide as a second generation antiandrogen for treatment of advanced prostate cancer
por: Semenas, Julius, et al.
Publicado: (2013)